Arthur S. Kirsch, Director of Atea Pharmaceuticals AVIR, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $1.7M. The latest trade was on 06/18.

AK

AK

Arthur S. Kirsch

Director

Company

Atea Pharmaceuticals AVIR

First filing

23/06/21

Trades

12 trades

Buys / sales

0 / 3

12-month net buying

−$1.7M

Last trade

06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
LiquidiaLQDA	Open-market sale	06/01–06/03	06/03	30,000 sh3 trades	$57.71avg.	$1,731,300	−100.0%